Cardiovascular disease is the major cause of death in patients with chronic kidney disease, this study prospectively enrolled 67 patients with ESRD to quantify evaluate the difference in left ventricular (LV) regional myocardial microvascular function using cardiac magnetic resonance (CMR), and to discuss the factors that may affect myocardial damage in the clinical treatment. The results confirmed that the first-pass perfusion CMR can early defect the myocardial deformation and dysfunction in ESRD patients, and the treatment time may be a risk factor for the cardiovascular disease in the patients with CKD.
This abstract and the presentation materials are available to members only; a login is required.